## DOC: Healthpeak Properties, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -5.6% below STRENGTH zone (3.0-6.0%); PEG 4.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($16.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?**
- Source: Yahoo News Malaysia | 20251204T112000 | Neutral | Relevance: 60%
- The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), launched in 2012, is a smart beta fund focusing on large-cap value stocks with high dividends and low volatility. It boasts over $3.06 billion in assets, an expense ratio of 0.30%, and a trailing dividend yield of 3.87%. The fund's top sectors include Real Estate, Consumer Staples, and Utilities, with Pfizer, Altria, and Healthpeak Properties among its largest holdings.

**2. Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?**
- Source: www.sharewise.com | 20251204T190907 | Neutral | Relevance: 55%
- The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) is a smart beta ETF launched in 2012, designed to track the S&P 500 Low Volatility High Dividend Index, offering exposure to the large-cap value segment. With over $3.06 billion in assets and a 0.30% expense ratio, SPHD focuses on high dividend yields and low volatility stocks. The fund has a 12-month trailing dividend yield of 3.87% and has performed moderately this year.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Wells Fargo | $19 | $18 | +6% |
| 2025-11-12 | Baird | $20 | $21 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-12 | Baird | main | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (-1.9%)
- Blackrock Inc.: 10.5% (-1.7%)
- JPMORGAN CHASE & CO: 8.1% (+182.0%)
- State Street Corpora: 7.1% (+1.8%)
- Principal Financial : 3.9% (-3.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.7% 5d) with bearish MACD, trend may be turning.
2. Valuation risk: PEG 4.1x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 5.9% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.08 signals overvaluation risk, limited margin of safety. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 1.09 |
| 52W Range | $15.71 - $21.28 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.08 |
| Forward P/E | 68.7 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 0.1% to -5.6% (-5.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.6pp (needs >3.0% for momentum thesis). Underperforming sector by 3.4pp, stock-specific weakness. Below SMA200 (0.94x), long-term trend not supportive. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.60% (CS: 4) | Weak |
| RSI_14 | 38.2 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.944x | Below |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $17.18
- **Stop Loss:** $16.40 (4.5% risk)
- **Target:** $17.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 641
- **Position Value:** $11,012.38
- **Portfolio %:** 11.01%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-05 (Est: $0.06)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.06 | $-0.18 | -403.2% |
| 2025Q2 | $0.06 | $0.06 | +12.2% |
| 2025Q1 | $0.04 | $0.06 | +40.7% |
| 2024Q4 | $0.05 | $0.05 | -4.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*